We accept MasterCard logo Visa logo American Express logo
Free Shipping Over $1000   |   5% Off First Order   |   Bulk Buy Discounts
Free Shipping Over $1000   |   5% Off First Order   |   Bulk Buy Discounts

Botulinum Toxin

Botulinum toxin type A (BTX-A) is a prescription neuromodulator that temporarily relaxes targeted muscles for aesthetic and therapeutic use. This page sets Western brands such as BOTOX®, DYSPORT®, and XEOMIN® beside Korean options including NABOTA®, BOTULAX®, and INNOTOX®, with notes on formulation, approvals, storage, and dosing. Medical Spa Rx representatives can guide qualified practitioners on brand comparisons, product documentation, and availability.

Find More with Just a Click!

Can’t spot what you need in our catalog? Fret not–just sign up for our expert consultations. We will provide the insights you need. We're here to guide you to your clinic's potential; no product browsing needed

Top Botulinum Toxin brands

Other information

What Is Botulinum Toxin and How Does It Work?

Medical Spa Rx gives licensed practitioners one place to compare botulinum toxin type A (BTX-A) brands used in aesthetic and therapeutic practice. Established Western formulations appear alongside Korean products, making it easier to examine origin, regulatory status, and handling requirements before selecting a product for botulinum toxin injections. If you are wondering how to buy botulinum toxin online, Medical Spa Rx representatives can provide information on brand differences, product documentation, and availability.

Botulinum toxin is a purified protein made by the bacterium Clostridium botulinum. Clinicians use it in tiny, measured doses to temporarily relax specific muscles. It is a prescription medicine, and only trained, licensed clinicians who know the anatomy of the treatment area should inject it. In aesthetic practice, it softens frown lines, crow’s feet, forehead lines, and neck bands. In medicine, it is used for chronic migraine, spasticity, cervical dystonia, overactive bladder, severe underarm sweating, and eyelid spasm.

Botulinum toxin type A blocks acetylcholine release by cleaving SNAP-25, a protein required for nerve signaling. The targeted muscle then relaxes temporarily until nerve function recovers. [2]

Botulinum Toxin Type A and Other Serotypes: Commercial Formulations

Botulinum toxin has seven recognized serotypes, designated A through G. Types A and B are used in clinical botulinum toxin products, with type A predominating in aesthetic and therapeutic practice. Type B, available as rimabotulinumtoxinB (MYOBLOC®), is used for selected neurological indications.

Botulinum Toxin Type A Formulations in Clinical Use

In 2009, the U.S. Food and Drug Administration (FDA) introduced distinct nonproprietary names for botulinum toxin products to help distinguish formulations with different potency characteristics. These names identify individual preparations whose dosing units are not interchangeable. Formulations discussed in this category include:

  • OnabotulinumtoxinA: BOTOX® and BOTOX® Cosmetic (AbbVie/Allergan), also sold as Vistabel® in some markets
  • AbobotulinumtoxinA: DYSPORT® and AZZALURE® (Ipsen, with Galderma handling aesthetics)
  • IncobotulinumtoxinA: XEOMIN® and BOCOUTURE® (Merz)
  • PrabotulinumtoxinA: NABOTA® (Daewoong), known as JEUVEAU® in the US
  • LetibotulinumtoxinA: BOTULAX® (Hugel), approved as LETYBO® in Europe and the US

Differences in potency units are an important consideration when evaluating whether to buy botulinum toxin wholesale across brands. These units are formulation-specific and cannot be interchanged. Although botulinum toxin cream is sometimes marketed online, the approved BTX-A products are injectables. [2]

Korean vs Western Botulinum Toxin: Why the Distinction Matters for Procurement

Western or Korean? That distinction can guide an initial comparison, but it shouldn’t determine product selection on its own. To buy botulinum toxin injections for clinical use, due diligence must include the formulation’s approved indications, evidence base, and regulatory standing in the intended market.

BOTOX®, DYSPORT®, and XEOMIN® are established FDA-approved formulations in Western markets. BOTOX® received its first U.S. approval in 1989 and has an extensive clinical evidence base.

Korea now has more botulinum toxin makers than any other country, with 19 products from 15 manufacturers. A 2026 review explains why Korean brands are gaining ground: [3]

  • Price pressure: heavy competition at home pushed prices down and encouraged makers to export
  • Growing approvals: prabotulinumtoxinA and letibotulinumtoxinA are now registered in both the US and Europe
  • Manufacturing standards: those approvals show the makers follow strict Good Manufacturing Practice rules

INNOTOX® stands out for its liquid format, eliminating the reconstitution step required by many lyophilized formulations. When deciding to buy BTX across Western and Korean brands, account for preparation requirements, product authorization, and available clinical documentation.

Western-Market Formulations and Brand Names

Before clinics order botulinum toxin, they should review each formulation’s approval history, labeled indications, and brand-specific dosing instructions. The Western brands below have long regulatory histories that can inform that comparison.

  • BOTOX®: AbbVie’s onabotulinumtoxinA, the product other toxins are usually compared with. Its US labels cover four aesthetic areas plus medical uses such as chronic migraine and spasticity. [4]
  • DYSPORT®: Ipsen’s abobotulinumtoxinA, approved for frown lines as well as cervical dystonia and spasticity. It uses its own unit scale, so its doses do not match BOTOX® doses one-to-one.
  • XEOMIN®: Merz’s incobotulinumtoxinA, made without the complexing proteins found in many other toxins. It can be kept at room temperature before mixing.
  • JEUVEAU®: the US name for prabotulinumtoxinA, made by Daewoong and marketed by Evolus. In 2019, it became the first Korean-made toxin approved in the US.
  • BOCOUTURE®: the name Merz uses for incobotulinumtoxinA in aesthetic practice outside the US. It is the same molecule as XEOMIN®.
  • AZZALURE®: abobotulinumtoxinA marketed by Galderma for aesthetic use in Europe. It is the same molecule as DYSPORT®.

Korean-Developed Formulations and Brand Names

These South Korean products range from FDA-approved molecules to brands registered mainly in Korea, so check each one’s status where you practice.

  • NABOTA®: Daewoong’s prabotulinumtoxinA, launched in Korea in 2013. The same molecule is approved as JEUVEAU® in the US and NUCEIVA® in Europe.
  • Re N Tox™: a BTX-A product from PharmaResearch Bio, registered in Korea for aesthetic use and also known as Lientox®.
  • MEDITOXIN®: Medytox’s original toxin, registered in 2006 as Neuronox®, Korea’s first BTX product. It holds both aesthetic and therapeutic registrations in Korea.
  • LIZTOX®: a freeze-dried BTX-A from Huons BioPharma, registered in Korea for aesthetic use and also sold as Hutox®.
  • INNOTOX®: Medytox’s liquid nivobotulinumtoxinA, first registered in Korea in 2013. It is currently in clinical studies in the US.
  • BOTULAX®: Hugel’s letibotulinumtoxinA, introduced in Korea in 2009. The same molecule was approved as LETYBO® in Europe in 2022 and in the US in 2024.

Regulatory Status and FDA Approvals

Botulinum toxin is prescription-only, and its use is subject to applicable professional licensing and prescribing requirements. FDA-approved BTX-A brands include BOTOX®, DYSPORT®, and XEOMIN®. JEUVEAU® and LETYBO® also hold U.S. approvals, but those approvals apply to their specific labeled products. They should not automatically be extended to formulations marketed internationally as NABOTA® or BOTULAX® under those brand names.

A plan to buy BTX across jurisdictions requires checking authorization for each marketed name and presentation; approval does not automatically extend to another brand.

Four of the Korean brands listed above are registered in Korea and for export, without US or European approval: Re N Tox™, MEDITOXIN®, LIZTOX®, and INNOTOX®. For US products, current labels are available on DailyMed, the National Library of Medicine’s database of FDA-approved labeling.

Conditions and Indications for Botulinum Toxin Injections

Botulinum toxin treatment is used across multiple facial and neck areas, with applications depending on the product’s approved indications and clinical context. Treatment planning should account for individual anatomy, target-muscle activity, and appropriate injection technique.

Aesthetic Botulinum Toxin Injections

  • FDA-approved aesthetic areas: frown lines, crow’s feet, forehead lines, and platysma (neck) bands, under the BOTOX® Cosmetic label. [5]
  • Common off-label areas: brow shaping, lip lines, gummy smile, and masseter slimming for a softer jawline, guided by expert consensus. [1]
  • Hyperhidrosis: severe underarm sweating that topical treatments do not control.

Therapeutic Botulinum Toxin Injections

  • Chronic migraine: Botox for migraines is approved for adults with 15 or more headache days a month. It is given as 155 units across seven head and neck areas every 12 weeks. [4]
  • Other medical uses: cervical dystonia, blepharospasm, strabismus, overactive bladder, and spasticity in patients aged 2 and up.

In physical therapy, botulinum toxin is mainly used for spasticity. Easing tight muscles can make stretching and movement training easier. The BOTOX® label recommends guidance using EMG, nerve stimulation, or ultrasound for certain injections. To purchase botulinum toxin for a therapeutic service, clinics should first confirm the exact product’s approved indications and labeling in their jurisdiction.

Botulinum Toxin vs Botox®: Same Thing or Not?

Botulinum toxin is the active substance; BOTOX® is AbbVie’s onabotulinumtoxinA brand. People sometimes use “botox injections” to describe other formulations, prompting searches such as “botulinum toxin botox.” The botulinum toxin vs Botox® distinction matters because dosing units are not interchangeable.

Dosing, Onset, and How Long Results Last

Each brand uses a formulation-specific potency assay. Published comparisons have reported approximate 1:1 relationships between XEOMIN® and BOTOX® and ratios around 2.5:1 to 3:1 for DYSPORT® relative to BOTOX®. However, these research comparisons are not official unit conversions and should not replace product-specific prescribing instructions. [2] Before a clinic decides to buy botulinum toxin injections across brands, the team should check each formulation’s labeled dosing and dilution instructions rather than rely on a shared conversion chart.

Most products come as a powder that is mixed with sterile, preservative-free saline before use. Careless mixing can weaken the effect. INNOTOX® is the exception, since it is already a liquid.

Muscle weakness usually appears within three to seven days, and patients are reviewed around the 10- to 14-day mark. Aesthetic results last at least three months, often four to five, depending on the area, dose, and product. The same range applies when patients ask how long Botox lasts. Some medical uses last longer: in BOTOX® trials for underarm sweating, the effect lasted a median of 201 days. [4]

Side Effects, Warnings, and Safe Use

BTX-A has a strong safety record across aesthetic and medical uses, though professionals may expect mild symptoms. Common botulinum toxin side effects include pain, bruising, and swelling at the injection site, and a cold pack right after treatment can help. Reported adverse effects include eyelid or brow ptosis following upper-face treatment and dysphagia after injections for cervical dystonia. These risks depend on the treatment indication, anatomical area, and product-specific precautions. [4]

FDA-approved botulinum toxin products carry boxed warnings about the potential spread of toxin effects beyond the injection site. Symptoms may occur hours to weeks after administration and can include potentially life-threatening swallowing or breathing difficulties. The labeling identifies children treated for spasticity as a particularly vulnerable population.

  • Avoid using in patients allergic to any botulinum toxin product or its ingredients, or with an infection at the injection site
  • Use with caution in patients with neuromuscular disorders such as myasthenia gravis or ALS, who face a higher risk of serious weakness
  • Pregnancy: there is no solid human data, and animal studies suggest possible harm to the baby

Proper administration technique, which includes the right dose, dilution, depth, and placement, remains the best way to keep these risks low.

Why Clinicians Rely on Botulinum Toxin Treatment

Neuromodulator injections rank among the most frequently performed minimally invasive aesthetic procedures in the annual statistics from the American Society of Plastic Surgeons. Clinicians value:

  • Temporary, adjustable aesthetic results
  • Outpatient administration with individualized aftercare
  • Therapeutic applications including chronic migraine, cervical dystonia, and overactive bladder

Storage and Cold Chain

Botulinum toxin products are sensitive to environmental conditions, including excessive heat. However, acceptable storage temperatures vary by formulation, so handling requirements must follow the manufacturer’s instructions rather than a general temperature threshold.

  • Before mixing: Store BOTOX® vials at 2°C to 8°C. Most other toxins also need cold storage, while XEOMIN® and BOCOUTURE® can be kept at room temperature.
  • After mixing: keep BOTOX® at 2°C to 8°C and use within 24 hours. Other brands set their own limits. [4]
  • On arrival: Check shipping documentation, packaging, and product-specific authenticity features. Verify that tamper-evident seals, lot details, and manufacturer markings are consistent with the applicable product labeling. Contact the manufacturer if any authenticity concerns arise.

A vial’s appearance alone cannot establish whether appropriate transport conditions were maintained. Clinics preparing to order botulinum toxin online should review the manufacturer’s transport specifications and any documentation needed to verify proper handling. Medical Spa Rx representatives can discuss general packaging and receipt considerations.

How Should Clinics Compare Costs Before They Buy Botulinum Toxin Wholesale?

Comparing cost per treatment provides a more useful basis for evaluating formulations than vial price alone, since potency units are not interchangeable between brands. The cost of botulinum toxin injections also depends on the treatment area and professional fees.

To order botulinum toxin wholesale responsibly, a clinic should evaluate per-treatment economics, authorized market status, and storage requirements. Medical Spa Rx representatives can provide general information on pricing considerations and documentation.

How to Buy Botulinum Toxin Online: Information for Licensed Practitioners

Trying to buy botulinum toxin wholesale for a multi-injector practice involves more than comparing volume pricing. Check product authorization, professional eligibility, and lot traceability for the destination market.

For those asking how to buy botulinum toxin online, Medical Spa Rx representatives can explain formulation differences, documentation, and availability without substituting for local regulatory advice.

Frequently Asked Questions

1. What should practitioners compare before choosing a botulinum toxin type A formulation?

Compare the formulation’s nonproprietary name, potency units, approved indications, preparation, storage, and regulatory status. Each BTX-A product requires assessment against its own labeling.

2. Why can’t BTX products be compared by vial units alone?

Each brand uses its own potency assay, so equal vial-unit counts do not establish equivalent doses. Follow formulation-specific prescribing and reconstitution instructions.

3. Does “Botox®” refer to every botulinum toxin injection?

No. BOTOX® is AbbVie’s brand of onabotulinumtoxinA, while botulinum toxin is the broader drug category. DYSPORT®, XEOMIN®, JEUVEAU®, NABOTA®, and other BTX-A products use their own formulations, labeling, and unit systems. The distinction matters particularly when practitioners compare dosing, indications, and product requirements.

4. How should clinics compare Western and Korean botulinum toxin brands?

Compare authorization in the intended market, clinical evidence, potency units, storage, and dosing requirements. Manufacturing origin provides context, but Western or Korean branding alone should not determine product choice.

5. Which treatment uses should be checked before selecting a BTX product?

Botulinum toxin injections are used across aesthetic and therapeutic practice, but approved indications vary by formulation and jurisdiction. Depending on the product, labeled uses may include glabellar lines, crow’s feet, forehead lines, neck bands, chronic migraine, hyperhidrosis, cervical dystonia, blepharospasm, spasticity, or overactive bladder. Other aesthetic applications may be off-label, so practitioners should confirm the current product labeling before treatment.

6. How quickly do botulinum toxin results develop, and how long can they last?

Treatment timelines depend on the formulation and indication. Changes may begin during the first week, while fuller effects are commonly assessed after approximately two weeks. Aesthetic improvements generally persist for three to four months, although certain therapeutic applications can last longer. Dose, target muscle, and individual response also affect duration.

7. What safety information should clinicians review before administering BTX?

Common reactions include temporary injection-site discomfort, bruising, swelling, or headache. Treatment-area-specific effects can include eyelid or brow ptosis with upper-face injections and dysphagia with certain neck indications. Botulinum toxin products also carry warnings regarding possible spread of toxin effect beyond the injection site. Always check contraindications, precautions, and administration requirements against the current labeling for the specific product.

8. What should clinics verify when comparing online BTX-A sources?

Anyone assessing how to purchase botulinum toxin online should request current product authorization, lot traceability records, applicable temperature-handling information, and verification of professional eligibility. These checks help practitioners assess the documentation behind each formulation. Medical Spa Rx representatives can provide guidance on brand information and availability.

The page and all of its displayed contents are for medical professionals, designed to inform only, and not as a replacement for medical advice.

Citations

[1] Sundaram, Hema et al. “Global Aesthetics Consensus: Botulinum Toxin Type A–Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.” Plastic and reconstructive surgery vol. 137,3 (2016): 518e-529e. doi:10.1097/01.prs.0000475758.63709.23

[2] Samizadeh, Souphiyeh, and Koenraad De Boulle. “Botulinum neurotoxin formulations: overcoming the confusion.” Clinical, cosmetic and investigational dermatology vol. 11 273-287. 30 May. 2018, doi:10.2147/CCID.S156851

[3] Dressler, Dirk et al. “Korean botulinum toxins.” Journal of neural transmission (Vienna, Austria : 1996) vol. 133,6 (2026): 971-975. doi:10.1007/s00702-025-03076-x

[4] U.S. Food and Drug Administration. “HIGHLIGHTS of PRESCRIBING INFORMATION | BOTOX ® (onabotulinumtoxinA) for Injection.” AbbVie Inc., US Food and Drug Administration, 2023, www.rxabbvie.com/pdf/botox_pi.pdf.

[5] AbbVie Inc. “BOTOX® Cosmetic (OnabotulinumtoxinA) for Injection, for Intramuscular Use: Full Prescribing Information.” DailyMed, revised Oct. 2024, dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=485d9b71-6881-42c5-a620-a4360c7192ab.

Top Botulinum Toxin brands

We work with leading international brands specializing in Botulinum Toxin , selected for their clinical reliability, regulatory compliance, and consistent treatment outcomes. These are our most recommended suggestions:

Written and reviewed by the Medical Spa Rx Editorial Team 

All clinical and product claims on this page have been checked against peer-reviewed research, manufacturer data, and regulatory sources in accordance with our Editorial Policy .